Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, she pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys teaching and working with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J Risk of second breast cancer events with chronic opioid use in breast cancer survivors 2019 May;28(5):740-753. doi: 10.1002/pds.4779. Epub 2019-04-03. PubMed
Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J Use of antidepressants after colon cancer diagnosis and risk of recurrence 2019 Apr;28(4):750-758. doi: 10.1002/pon.5015. Epub 2019-02-14. PubMed
Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ Time to fecal immunochemical test completion for colorectal cancer screening 2019 Apr;25(4):174-180. PubMed
Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Boggs JM, Burnett-Hartman AN, Sterrett A, Fujii M, Chubak J Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study 2019 Mar 27;19(1):270. doi: 10.1186/s12885-019-5493-8. Epub 2019-03-27. PubMed
Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V, PROSPR consortium Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort 2019 Mar 15;144(6):1460-1473. doi: 10.1002/ijc.31940. Epub 2018-12-20. PubMed
Chen Y, Wang J, Chubak J, Hubbard RA Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence 2019 Feb;28(2):264-268. doi: 10.1002/pds.4680. Epub 2018-10-30. PubMed
Aiello Bowles EJ, Crane PK, Walker RL, Chubak J, LaCroix AZ, Anderson ML, Rosenberg D, Keene CD, Larson EB Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain 2019 Jan;68(3):1071-1083. doi: 10.3233/JAD-180942. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.